Yuqiu Jiang

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

Massimo Cristofanilli, Nicholas C. Turner, Igor Bondarenko et al. · The Lancet Oncology · 2016 · 1.8K citations

Medicine, Oncology, Pharmacology +17

Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions

Dmitri Talantov, Abhijit Mazumder, Jack X. Yu et al. · Clinical Cancer Research · 2005 · 528 citations · Full text

Medicine, Dermatology, Oncology +17

<i><scp>KRAS</scp></i> and <i><scp>BRAF</scp></i> mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue

Bianca Mostert, Yuqiu Jiang, Anieta M. Sieuwerts et al. · International Journal of Cancer · 2012 · 130 citations

Medicine, Molecular Medicine, Oncology +17

Detection of Androgen Receptor Mutations in Circulating Tumor Cells in Castration-Resistant Prostate Cancer

Yuqiu Jiang, John F. Palma, David B. Agus et al. · Clinical Chemistry · 2010 · 130 citations

Medicine, Molecular Biology, Oncology +17

Anterior gradient 2 (AGR2): Blood‐based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype

Kian Kani, Paymaneh D. Malihi, Yuqiu Jiang et al. · The Prostate · 2012 · 86 citations

Medicine, Oncology, Urology +17